Document 3100
 DOCN  M94A3100
 TI    The HIV outpatient study (HOPS): early results.
 DT    9412
 AU    Marlowe S; Moorman A; Holmberg S; HOPS Investigators/Health Research
       Network, Atlanta, GA.
 SO    Int Conf AIDS. 1994 Aug 7-12;10(1):153 (abstract no. PB0037). Unique
       Identifier : AIDSLINE ICA10/94369475
 AB    OBJECTIVE: To monitor trends in demographics, symptoms, diagnoses, and
       treatments of HIV-infected outpatients, especially early in infection.
       METHODS: We analyzed data electronically charted by trained clinic
       personnel on HIV-infected outpatients' visits to clinician offices in
       the following US cities: Atlanta, GA, Tampa, FL, Portland, OR, Okland,
       CA, and north Los Angeles, CA. The PC-based electronic system allows
       immediate access to site-specific data. RESULTS: In the first 6 months
       445 patients were interviewed and examined during 1,113 visits, of which
       10% were event-triggered and 90% were for routine care. Median age of
       patients was 37 years; 91% were male; 74% were white, 12% Afr/American,
       and 4% Hispanic; 88% were homo/bisexual men, and 6% were injecting drug
       users. Sources of payment were private insurance (71%), Medicaid (14%),
       and Medicare (4%); 50% of patients were working fulltime, 38% were
       disabled/not working. Of 367 patients with a CD4 count during the
       observation period, 52% had < 200, 33% had 200-499, and 16% had > or =
       500 cells/microliter. Common symptoms included mild/moderate fatigue
       (12%), diarrhea (5%), paresthesia (5%), productive cough (5%), headaches
       (4%), and weight loss (3%). Frequent diagnoses included candidiasis
       (14%), sinusitis (6%), PCP (4%), KS (4%), peripheral neuropathy (5%),
       herpes simplex (4%), Mycobacterium avium infection (4%), wasting (4%),
       and bronchitis (4%). During the observed clinic visits 56% of patients
       had taken AZT, 25% DDI, 22% DDC, and 8% D4T. CONCLUSIONS: These
       preliminary data provide insight into current characteristics and
       treatment of HIV-infected, non-hospitalized patients. To better monitor
       trends, the HOPS is expanding to include sites with greater demographic
       and risk group diversity.
 DE    Adult  AIDS-Related Opportunistic Infections/EPIDEMIOLOGY  Ethnic Groups
       Female  Human  HIV Infections/*EPIDEMIOLOGY/PHYSIOPATHOLOGY/*THERAPY
       Insurance, Health  Leukocyte Count  Male  Medicaid  Medicare
       Outpatients/*STATISTICS & NUMER DATA  Sex Behavior  Substance Abuse,
       Intravenous  T4 Lymphocytes  United States/EPIDEMIOLOGY  MEETING
       ABSTRACT

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).